Two house bills look to continue pandemic-induced policy practices
Shawna De La Rosa | Mar 5, 2021 | Maryland
Federal court rules against hospitals in HHS price transparency lawsuit
Michael Goldberg | Jun 23, 2020 | Federal
$30 insulin co-pay cap passes Legislature
Michael Goldberg | Mar 12, 2020 | Utah
Texas drug-pricing transparency bill passes full Legislature
Sara Gentzler | May 24, 2019 | Texas
Senate pharmaceutical hearings: a run-down of emerging themes
Marjie High | Feb 28, 2019
U.S. Senators shined a light on drug pricing this week as the CEOs of Pfizer, Merck, AbbVie, AstraZeneca, and other large pharmaceutical companies appeared before the Senate Finance Committee. The hearings have been widely covered, and we've noticed some emerging themes. We’ve curated a run-down of the best reporting of
What They're Watching: Kristine Ashcraft, YouScript
Emily Boerger | Dec 12, 2018 | Oregon
Kristine Ashcraft is the Chief Executive Officer of YouScript, a company dedicated to precision medication management. She joins us in this edition of What They're Watching to discuss pharmacogenetic testing. “I've been in the precision medicine space, specifically pharmacogenetic testing, since 2000. And way back then there was an article